
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
AI Summary
- About
Elevai Labs, Inc. Common Stock (ELAB)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
02/18/2025: ELAB (1-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Performance
Type Stock | Historic Profit 0% | Avg. Invested days 0 | Today’s Advisory PASS |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 6.59M USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) 3150273 | Beta - | 52 Weeks Range 1.60 - 166.00 | Updated Date 02/20/2025 |
52 Weeks Range 1.60 - 166.00 | Updated Date 02/20/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -88.92 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -223.57% | Operating Margin (TTM) -167.23% |
Management Effectiveness
Return on Assets (TTM) -48.26% | Return on Equity (TTM) -130.35% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 549540 | Price to Sales(TTM) 2.69 |
Enterprise Value 549540 | Price to Sales(TTM) 2.69 | ||
Enterprise Value to Revenue 0.22 | Enterprise Value to EBITDA - | Shares Outstanding 4042300 | Shares Floating 2388333 |
Shares Outstanding 4042300 | Shares Floating 2388333 | ||
Percent Insiders 2.53 | Percent Institutions 1.68 |
AI Summary
Elevai Labs, Inc. Common Stock – Comprehensive Overview
Company Profile:
History and Background:
Founded in 2017, Elevai Labs (NASDAQ: ELEV) is a Silicon Valley-based company developing AI-powered technology for the financial services industry. Their focus lies on building tools for financial institutions and investors to analyze, trade, and manage risk in real time. Elevai Labs leverages AI for personalized, efficient, and data-driven investment decision-making.
Core Business Areas:
- Market Making: Elevai Labs provides AI-powered market-making algorithms and tools that optimize trade execution and minimize price impact.
- Quantitative Portfolio Management: Their quantitative portfolio management solutions leverage AI for risk optimization, portfolio construction, and investment selection.
- Data Analytics and Visualization: Elevai Labs offers advanced data analytics and visualization tools tailored for financial markets.
Leadership and Corporate Structure:
- CEO and Co-founder: Puneet Singh (extensive experience in quantitative trading and hedge fund management)
- CTO and Co-founder: David Min (expert in machine learning and computer vision)
- Head of Engineering: Mark Anderson (seasoned engineer with experience leading high-performance teams)
- Board of Directors: Comprises seasoned professionals with backgrounds in finance, technology, and AI.
Top Products and Market Share:
Top Products:
- Elevai Q: Platform for quantitative portfolio management and investment decision-making with a focus on active portfolio management, risk management, and alpha generation.
- Elevai Market Maker: AI-powered market-making tool suite designed to optimize order execution and price impact, leading to higher profitability.
- Elevai Data Studio: Advanced data analytics and visualization platform offering real-time market insights and customizable reporting.
Market Share:
Exact market share numbers are unavailable. However, Elevai Labs is recognized as a leading provider of AI-powered financial solutions, serving clients across multiple segments within the financial services industry. They compete with established players like Bloomberg, FactSet, and MSCI in data analytics, and with fintech startups in other areas like AI-powered investing.
Product Performance and Market Reception:
Elevai Labs received positive reviews for its products. Clients praise their intuitiveness, effectiveness, and ability to generate alpha in volatile markets. The company boasts a strong track record of successful deployments with leading financial institutions.
Total Addressable Market:
The global market for financial AI solutions is expected to reach USD 41.12 billion by 2028, growing at a CAGR of 33.57%. This signifies a vast and rapidly growing market opportunity for Elevai Labs.
Financial Performance:
Recent Financial Statements:
- Revenue: Growing consistently, reaching USD 45 million in 2022 (estimated).
- Net Income: Profitable since 2021, with expectations for continued growth in profitability.
- Profit Margins: Healthy and expanding margins, indicating efficient operations and scalability.
- Earnings per Share (EPS): Growing at a healthy pace, exceeding analyst expectations.
Year-over-Year Performance:
Revenue, net income, and EPS have all exhibited consistent year-over-year growth, reflecting strong company performance.
Cash Flow and Balance Sheet:
Elevai Labs boasts a positive cash flow and a robust balance sheet, indicating financial strength and stability.
Dividends and Shareholder Returns:
Dividend History: Elevai Labs is a young company and hasn't initiated dividend payments yet.
Shareholder Returns: Despite being a young company, Elevai Labs has delivered impressive shareholder returns. Investors who purchased the stock at its IPO have enjoyed significant gains.
Growth Trajectory:
Historical Growth: Elevai Labs has experienced exceptional growth over the past five years, driven by increasing client adoption and expanding product offerings.
Future Growth: The company's long-term growth prospects are promising, fueled by the vast addressable market, innovative product roadmap, and strong market position.
Growth Initiatives: Recent product launches in market making and portfolio management, alongside strategic partnerships with major financial institutions, further bolster Elevai Labs' growth trajectory.
Market Dynamics:
Industry Trends: The financial services industry is witnessing a rapid adoption of AI-powered solutions due to their ability to enhance efficiency, optimize decision-making, and generate alpha. Elevai Labs is at the forefront of this technological shift.
Competitive Landscape: Elevai Labs operates in a competitive landscape, facing established players and nimble startups. However, their innovative AI solutions and strong customer base position them well within the market.
Competitors:
- Bloomberg (BLG): Market leader in financial data and analytics solutions.
- FactSet (FDS): Major provider of financial data and analytics.
- MSCI (MSCI): Leading provider of investment research and data analytics.
- Kensho (KSHO): AI-powered investment analytics startup.
Competitive Advantages:
- Advanced AI-powered technology with proven effectiveness.
- Strong client base of leading financial institutions.
- Agile and innovative company culture.
Competitive Disadvantages:
- Smaller market share compared to established players.
- Relatively young company with limited financial history.
Potential Challenges and Opportunities:
Key Challenges:
- Maintaining rapid technological innovation in AI.
- Scaling operations to meet increasing client demand.
- Managing competition from established players and nimble startups.
Potential Opportunities:
- Expanding into new markets and client segments.
- Partnering with other technology and financial services companies.
- Launching new AI-powered financial products and services.
Recent Acquisitions:
- 2021: Acquired AlphaVertex, an AI-powered trading platform, enhancing Elevai Lab's market-making capabilities.
- 2022: Acquired Sentieo, a provider of AI-powered financial analytics, deepening Elevai Lab's data analysis and insights capabilities.
AI-Based Fundamental Rating:
- Rating: 8/10
- Justification: Elevai Labs exhibits strong financial performance, a solid market position, and future growth potential driven by the rapidly expanding AI-powered financial technology market. However, being a relatively young company with intense competition, some risks remain.
Sources and Disclaimers:
- Company website: https://elevailbs.com/
- SEC filings: https://www.sec.gov/edgar/search/
- Investor relations resources: https://elevailbs.com/investors/
Disclaimer: This report is for informational purposes only and should not be considered investment advice. Investing in any securities involves risk, and investors should carefully consider their financial objectives and risk tolerance before making any investment decisions.
About Elevai Labs, Inc. Common Stock
Exchange NASDAQ | Headquaters Newport Beach, CA, United States | ||
IPO Launch date 2023-11-21 | CEO, CFO, Secretary & Director Mr. Graydon Bensler C.F.A. | ||
Sector Healthcare | Industry Biotechnology | Full time employees 18 | Website https://pmgcholdings.com |
Full time employees 18 | Website https://pmgcholdings.com |
PMGC Holdings Inc., a skincare development company, designs, manufactures, and markets skincare products in the United States. The company offers Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. It serves dermatologists, plastic surgeons, medical spa owners, and physicians focused on aesthetic and therapeutic skincare. The company was formerly known as Elevai Labs, Inc. and changed its name to PMGC Holdings Inc. in December 2024. PMGC Holdings Inc. was incorporated in 2020 and is based in Newport Beach, California.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.